Dying right to live longer: Positing apoptosis as a link between maternal autoantibodies and congenital heart block

Lupus

Volumn 17, Issue 2, 2008, Pages 86-90

  Buyon, Jill P ^a,b   Clancy, R M ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TCH 407 ^*  (United States)

Author keywords

Anti SSA Ro; Anti SSB La; CHB; Neonatal lupus

Indexed keywords

AUTOANTIBODY; LA ANTIBODY; MATERNAL ANTIBODY; RO ANTIBODY; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; ATRIOVENTRICULAR BLOCK; CELL CULTURE; CELL FUNCTION; CONGENITAL HEART BLOCK; CYTOKINE RELEASE; ENDOCARDIUM; FIBROSIS; HEART ATRIOVENTRICULAR NODE; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE CONDUCTION SYSTEM; HUMAN; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LABORATORY; MACROPHAGE; MEDICAL RESEARCH; MYOFIBROBLAST; PATHOGENESIS; PATHOGENICITY; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TISSUE INJURY;

ANTIBODIES, ANTINUCLEAR; APOPTOSIS; AUTOANTIBODIES; FEMALE; HEART BLOCK; HUMANS; MATERNAL-FETAL EXCHANGE; MYOCYTES, CARDIAC; PREGNANCY;

EID: 40449128169     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203307085115     Document Type: Review

References (38)

1. McCue CM, Mantakas ME, Tingelstad JB, Ruddy S. Congenital heart block in newborns of mothers with connective tissue disease. Circulation 1977; 56: 82-90.
2. Chameides L, Truex RC, Vetter V, Rashkind W J, Galioto F M, Jr, Noonan JA. Association of maternal systemic lupus erythematosus with congenital complete heart block. N Engl J Med 1977; 297: 1204-1207.
3. Buyon J P and Clancy RM. Neonatal lupus. In Wallace DJ, HBH Dubois eds. Lupus Erythematosus. Lippincott Williams & Wilkins, 2006: 1058-1080.
4. Lee LA. Neonatal lupus erythematosus. J Invest Dermatol 1993; 100: 9S-13S.
5. Buyon JP and Winchester R. Congenital complete heart block. A human model of passively acquired autoimmune injury. Arthritis Rheum 1990; 33: 609-614.
6. Buyon JP, Waltuck J, Kleinman C, Copel J. In utero identification and therapy of congenital heart block. Lupus 1995; 4: 116-121.
7. Moak JP, Barron K S, Hougen TJ et al. Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela. J Am Coll Cardiol 2001; 37: 238-242.
8. Nield LE, Silverman E, Taylor GP et al. Maternal anti-Ro and anti-La antibody-associated endocardial fibroelastosis. Circulation 2002; 105: 843-848.
9. Brucato A, Frassi M, Franceschini F et al. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 2001; 44: 1832-1835.
10. Waltuck J, Buyon JP. Autoantibody-associated congenital heart block: outcome in mothers and children. Ann Intern Med 1994; 120: 544-551.
11. Buyon JP, Hiebert R, Copel J et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998; 31: 1658-1666.
12. Friedman DM, Kim MY. Utility of cardiac monitoring in fetuses at risk of congenital heart block: The PR interval and dexamethasone evaluation (PRIDE) prospective study [abstract]. Arthritis Rheum 2006; 54: S689.
13. Askanase AD, Friedman DM, Copel J et al. Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA/Ro-SSB/La antibodies. Lupus 2002; 11: 145-151.
14. Polizzi A, Ruggieri M, Vincent A. Pyridostigmine-induced microcephaly. Neurology 2001; 56: 1606-1607.
15. Festin MM, Limson GM, Haru OT. Autoimmune causes of recurrent pregnancy loss. Kobe J Med Sci 1997; 43: 143-157.
16. Salomonsson S, Dorner T, Theander E, Bremme K, Larsson P, Wahren-Herlenius M. A serologic marker for fetal risk of congenital heart block. Arthritis Rheum 2002; 46: 1233-1241.
17. Salomonsson S, Sonesson SE, Ottosson L. Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis and mediate congenital heart block. J Exp Med 2005; 201: 11-17.
18. Buyon JP, Slade SG, Reveille JP, Hamel JC, Chan EK. Autoantibody responses to the 'native' 52-kDa SS-A/Ro protein in neonatal lupus syndromes, systemic lupus erythematosus and Sjogren's syndrome. J Immunol 1994; 152: 3675-3684.
19. Clancy RM, Buyon JP, Ideda K et al. Maternal antibody responses to the 52-kd SSA/RO p200 peptide and the development of fetal conduction defects. Arthritis Rheum 2005; 52: 3079-3086.
20. Horsfall AC, Venables PJ, Taylor PV, Maini RN. Ro and La antigens and maternal anti-La idiotype on the surface of myocardial fibres in congenital heart block. J Autoimmun 1991; 4: 165-176.
21. Reichlin M, Brucato A, Frank MB et al. Concentration of autoantibodies to native 60-kd Ro/SS-A and denatured 52-kd Ro/SS-A in eluates from the heart of a child who died with congenital complete heart block. Arthritis Rheum 1994; 37: 1698-1703.
22. Alexander E, Buyon JP, Provost TT, Guarnieri T. Anti-Ro/SS-A antibodies in the pathophysiology of congenital heart block in neonatal lupus syndrome, an experimental model. In vitro electrophysiologic and immunocytochemical studies. Arthritis Rheum 1992; 35: 176-189.
23. Garcia S, Nascimento JH, Bonfa E et al. Cellular mechanism of the conduction abnormalities induced by serum from anti-Ro/SSA-positive patients in rabbit hearts. J Clin Invest 1994; 93: 718-724.
24. Boutjdir M, Chen L, Zhang ZH et al. Arrhythmogenicity of IgG and anti-52-kD SSA/Ro affinity-purified antibodies from mothers of children with congenital heart block. Circ Res 1997; 80: 354-362.
25. Buyon JP, Clancy R, Di Donato F et al. Cardiac 5-HT(4) serotoninergic receptors, 52kD SSA/Ro and autoimmune-associated congenital heart block. J Autoimmun 2002; 19: 79-86.
26. Clancy RM, Neufing PJ, Zheng P et al. Impaired clearance of apoptotic cardiocytes is linked to anti-SSA/Ro and -SSB/La antibodies in the pathogenesis of congenital heart block. J Clin Invest 2006; 116: 2413-2422.
27. Clancy RM, Askanase AD, Kapur RP et al. Transdifferentiation of cardiac fibroblasts, a fetal factor in anti-SSA/Ro-SSB/La antibody-mediated congenital heart block. J Immunol 2002; 169: 2156-2163.
28. Miranda-Carus ME, Askanase AD, Clancy RM et al. Anti-SSA/Ro and anti-SSB/La autoantibodies bind the surface of apoptotic fetal cardiocytes and promote secretion of TNF-alpha by macrophages. J Immunol 2000; 165: 5345-5351.
29. Casciola-Rosen LA, Anhalt G, Rosen A et al. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994; 179: 1317-1330.
30. Ucker DS. Death by suicide: one way to go in mammalian cellular development? New Biol 1991; 3: 103-109.
31. Hale AJ, Smith CA, Sutherland LC et al. Apoptosis: molecular regulation of cell death. Eur J Biochem 1996; 237: 884.
32. Takeda K, Yu ZX, Nishikawa T et al. Apoptosis and DNA fragmentation in the bulbus cordis of the developing rat heart. J Mol Cell Cardiol 1996; 28: 209-215.
33. Clancy RM, Kapur RP, Molad Y, Askanase AD, Buyon JP. Immunohistologic evidence supports apoptosis, IgG deposition and novel macrophage/fibroblast crosstalk in the pathologic cascade leading to congenital heart block. Arthritis Rheum 2004; 50: 173-182.
34. Caricchio R, Reap EA, Cohen PL. Fas/Fas ligand interactions are involved in ultraviolet-B-induced human lymphocyte apoptosis. J Immunol 1998; 161: 241-251.
35. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcot JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 1998; 101: 890-898.
36. Monks JD, Rosner D, Geske FJ et al. Epithelial cells as phagocytes: apoptotic epithelial cells are engulfed by mammary alveolar epithelial cells and repress inflammatory mediator release. Cell Death Differ 2005; 12: 107-114.
37. Arur S, Uche UE, RezaulK et al. Annexin I is an endogenous ligand that mediates apoptotic cell engulfment. Dev Cell 2003; 4: 587-598.
38. Clancy RM, Buyon JP. Clearance of apoptotic cells: TGF-beta in the balance between inflammation and fibrosis. J Leukoc Biol 2003; 74: 959-960.